• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产青霉素酶淋病奈瑟菌感染的流行病学:通过菌型分型和血清群分型进行分析

Epidemiology of penicillinase-producing Neisseria gonorrhoeae infections: analysis by auxotyping and serogrouping.

作者信息

Handsfield H H, Sandström E G, Knapp J S, Perine P L, Whittington W L, Sayers D E, Holmes K K

出版信息

N Engl J Med. 1982 Apr 22;306(16):950-4. doi: 10.1056/NEJM198204223061602.

DOI:10.1056/NEJM198204223061602
PMID:6801513
Abstract

Auxotyping and serogrouping by coagglutination were used to characterize penicillinase-producing Neisseria gonorrhoeae and penicillinase-negative isolates from the state of Washington, Shreveport (Louisiana), and the Far East. Fifty-four of 75 penicillinase-producing isolates (72 per cent) from Washington required proline for growth and were serogroup W-l (Pro-1), the predominant type of penicillinase-producing strains in the Philippines; none of 86 penicillinase-negative isolates from Washington was Pro-1 (P less than 0.0001). All 38 penicillinase-producing isolates from Shreveport required proline and were serogroup W-11 (Pro-11); five of 26 penicillinase-negative isolates (19 per cent) from Shreveport were also Pro-11 (P less than 0.0001) but had antigenic specificities within serogroup W-ll that distinguished them from the penicillinase-producing isolates. We conclude that the Washington and Shreveport outbreaks resulted from the spread of imported strains rather than transmission of penicillinase-encoding plasmids to indigenous gonococci. The Shreveport outbreak involved a single strain of penicillinase-producing N, gonorrhoeae and probably originated from a common source, whereas several types were involved in the multiple-source Washington outbreak, indicating repeated introduction of new strains.

摘要

采用凝聚试验进行菌型鉴定和血清群分类,以对来自华盛顿州、什里夫波特(路易斯安那州)和远东地区的产青霉素酶淋病奈瑟菌及非产青霉素酶分离株进行特征分析。来自华盛顿的75株产青霉素酶分离株中有54株(72%)生长需要脯氨酸,血清群为W-1(Pro-1),这是菲律宾产青霉素酶菌株的主要类型;来自华盛顿的86株非产青霉素酶分离株中无一为Pro-1(P<0.0001)。来自什里夫波特的38株产青霉素酶分离株均需要脯氨酸,血清群为W-11(Pro-11);来自什里夫波特的26株非产青霉素酶分离株中有5株(19%)也是Pro-11(P<0.0001),但在血清群W-11内具有与产青霉素酶分离株不同的抗原特异性。我们得出结论,华盛顿和什里夫波特的疫情是由输入菌株的传播引起的,而非青霉素酶编码质粒向本地淋球菌的传播。什里夫波特的疫情涉及单一菌株的产青霉素酶淋病奈瑟菌,可能源于同一来源,而多源的华盛顿疫情涉及多种类型,表明新菌株多次引入。

相似文献

1
Epidemiology of penicillinase-producing Neisseria gonorrhoeae infections: analysis by auxotyping and serogrouping.产青霉素酶淋病奈瑟菌感染的流行病学:通过菌型分型和血清群分型进行分析
N Engl J Med. 1982 Apr 22;306(16):950-4. doi: 10.1056/NEJM198204223061602.
2
Plasmid profile, serogrouping, and auxotyping of Neisseria gonorrhoeae isolates from Africa.来自非洲的淋病奈瑟菌分离株的质粒图谱、血清分型及辅助分型
Br J Vener Dis. 1983 Feb;59(1):41-3. doi: 10.1136/sti.59.1.41.
3
Outbreak of a distinct strain of penicillinase-producing Neisseria gonorrhoeae--King County, Washington.
MMWR Morb Mortal Wkly Rep. 1987 Nov 27;36(46):757-9.
4
Analysis of penicillinase-producing Neisseria gonorrhoeae isolates in Madrid (Spain) from 1983-85.1983 - 1985年西班牙马德里产青霉素酶淋病奈瑟菌分离株分析
Epidemiol Infect. 1987 Oct;99(2):455-62. doi: 10.1017/s0950268800067959.
5
Epidemiological characterisation of Neisseria gonorrhoeae isolates from the Far East.来自远东地区淋病奈瑟菌分离株的流行病学特征
Br J Vener Dis. 1983 Oct;59(5):285-8. doi: 10.1136/sti.59.5.285.
6
Leads from the MMWR. Outbreak of a distinct strain of penicillinase-producing Neisseria gonorrhoeae--King County, Washington.
JAMA. 1988 Jan 1;259(1):21, 25.
7
[Epidemic of penicillinase-producing, tetracycline-resistant gonococci; risk factors for their spread].[产青霉素酶、耐四环素淋病奈瑟菌的流行;其传播的危险因素]
Ned Tijdschr Geneeskd. 1995 Feb 11;139(6):283-8.
8
Localized outbreak of penicillinase-producing Neisseria gonorrhoeae. Paradigm for introduction and spread of gonorrhea in a community.产青霉素酶淋病奈瑟菌的局部暴发。社区淋病引入与传播的范例。
JAMA. 1989 Apr 28;261(16):2357-61.
9
Penicillinase-producing Neisseria gonorrhoeae.产青霉素酶淋病奈瑟菌
Am Fam Physician. 1981 Dec;24(6):117-9.
10
[Characteristics of penicillinase-producing strains of Neisseria gonorrhoeae isolated in France, 1979-1986].[1979年至1986年在法国分离出的产青霉素酶淋病奈瑟菌菌株的特征]
Pathol Biol (Paris). 1987 Jun;35(5 Pt 2):791-5.

引用本文的文献

1
Gonorrhea - an evolving disease of the new millennium.淋病——新千年不断演变的疾病。
Microb Cell. 2016 Sep 5;3(9):371-389. doi: 10.15698/mic2016.09.524.
2
Sexually transmitted diseases in the USA: temporal trends.美国的性传播疾病:时间趋势
Sex Transm Infect. 2007 Jul;83(4):257-66. doi: 10.1136/sti.2007.026245.
3
Antimicrobial resistance--pharmacological solutions.抗菌药物耐药性——药理学解决方案
Infection. 1999;27 Suppl 2:S32-4. doi: 10.1007/BF02561668.
4
Antimicrobial susceptibility testing of Neisseria gonorrhoeae and implications for epidemiology and therapy.淋病奈瑟菌的药敏试验及其对流行病学和治疗的意义。
Clin Microbiol Rev. 1993 Jan;6(1):22-33. doi: 10.1128/CMR.6.1.22.
5
Trends in susceptibility of Neisseria gonorrhoeae to ceftriaxone from 1985 through 1991.1985年至1991年淋病奈瑟菌对头孢曲松敏感性的变化趋势。
Antimicrob Agents Chemother. 1995 Apr;39(4):917-20. doi: 10.1128/AAC.39.4.917.
6
Sexually transmitted diseases: meeting the 1990 objectives--a challenge for the 1980s.性传播疾病:实现1990年目标——20世纪80年代的一项挑战。
Public Health Rep. 1982 Sep-Oct;97(5):409-16.
7
Control of sexually transmitted diseases: view from the United States of America.性传播疾病的防控:来自美国的视角
Br J Vener Dis. 1984 Oct;60(5):323-30. doi: 10.1136/sti.60.5.323.
8
Penicillinase producing Neisseria gonorrhoeae in Zurich, Switzerland.瑞士苏黎世产青霉素酶的淋病奈瑟菌
Br J Vener Dis. 1984 Jun;60(3):147-50. doi: 10.1136/sti.60.3.147.
9
Epidemiology of PPNG infections in the Netherlands: analysis by auxanographic typing and plasmid identification.荷兰产青霉素酶淋病奈瑟菌感染的流行病学:通过生长谱分型和质粒鉴定进行分析。
Br J Vener Dis. 1984 Jun;60(3):141-6. doi: 10.1136/sti.60.3.141.
10
Isolation of Neisseria gonorrhoeae on selective and nonselective media in a sexually transmitted disease clinic.在性传播疾病诊所的选择性和非选择性培养基上分离淋病奈瑟菌。
J Clin Microbiol. 1984 Feb;19(2):218-20. doi: 10.1128/jcm.19.2.218-220.1984.